查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404644

细胞重编程市场规模、份额、趋势分析报告：按技术、应用、最终用途、地区和细分市场预测，2024-2030 年

Cell Reprogramming Market Size, Share & Trends Analysis Report By Technology (Episomal Reprogramming, mRNA Reprogramming), By Application (Therapeutic, Research), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 119 Pages | 商品交期: 2-10个工作天内

价格

细胞重编程市场成长与趋势：

根据Grand View Research, Inc.最新报告，预计到2030年，全球细胞重编程市场规模将达到6.642亿美元，2024年至2030年复合年增长率为8.52%。

癌症研究中越来越多地采用细胞重编程以及对细胞重编程的日益关注等因素预计将推动市场成长。此外，对主要企业之间的合作研究和伙伴关係的重视预计将促进市场成长。 mRNA 重编程技术的进步使得能够利用身体组织快速、安全、有效率地产生临床级人类 iPS 细胞。此外，由于 mRNA 较小，因此转染过程比其他重编程载体更容易。当使用难以重编程的样本时，mRNA重编程可将重编程效率提高1%。

此外，此方法可以更快速、更安全地从人体组织产生高品质的人类iPS细胞，增加了对mRNA重编程技术的需求。它还具有将人类干细胞重新编程到原始状态的能力，使它们能够重现其最早的发育阶段。例如，2022 年 3 月，巴布拉汉姆研究所的研究人员发现了促进此初始化过程的关键因素。这项新发现为研究人员简化并加速了幼稚多功能能干细胞的生成。此外，在政府和公共资金的大力支持下，细胞重编程正在不断发展。这种支持是对其为医疗保健领域带来的各种好处的回应，特别是在潜在的医疗应用方面。

此外，研究人员最近已将细胞重编程从实验室重新定位到临床。这种变化在各种临床和学术研究中都很引人注目，包括再生医学、疾病建模以及与药物毒性和药物研发相关的研究。细胞重编程的临床效用在再生医学中尤其明显。研究和学术机构领域的成长推动了旨在透过细胞重编程开发创新产品的策略性倡议的增加。例如，加州再生医学研究所资助研究小组将细胞重编程推进临床重点治疗应用。

细胞重编程市场报告亮点

  • 由于易于使用、速度快、安全和高效，同时从身体组织产生高品质的人类 iPS 细胞，mRNA 重编程技术细分市场在 2023 年占据最大的销售份额，为 32.67%。
  • 研究应用领域在 2023 年以 67.41% 的份额引领市场。成长的主要驱动力之一是利用干细胞进行细胞重编程领域的持续研究。
  • 2023 年，研究和学术最终用途领域占销售份额 67.41%。这种增长归因于细胞重编程在各种临床和学术研究计划中的使用，包括再生治疗、疾病建模和药物毒性/药物研发研究。
  • 由于该地区主要参与者的存在，北美在 2023 年占据全球行业的主导地位，销售额份额为 38.65%。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场体系展望
  • 市场动态
  • 产业分析工具

第四章科技业务分析

  • 细胞重编程市场：技术波动分析
  • 用仙台病毒重新编程
  • mRNA重编程
  • 游离重编程
  • 其他的

第五章 应用业务分析

  • 细胞重编程市场：应用变异分析
  • 研究
  • 治疗

第六章 最终用途业务分析

  • 细胞重编程市场：最终用途变异分析
  • 研究和学术机构
  • 生物技术和製药公司

第七章 区域业务分析

  • 2022 年及 2030 年细胞重编程市场占有率（按地区）
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第八章竞争形势

  • 公司分类
  • 策略规划
  • 2022 年企业市场分析
  • 公司简介/名单
    • Thermo Fisher Scientific, Inc.
    • Allele Biotech
    • ALSTEM
    • STEMCELL Technologies Inc.
    • Merck KGaA
    • Bio-Techne
    • REPROCELL
    • Lonza
    • FUJIFILM Corporation（Fujifilm Cellular Dynamics）
    • Mogrify Limited
Product Code: GVR-4-68039-966-2

Cell Reprogramming Market Growth & Trends:

The global cell reprogramming market size is expected to reach USD 664.2 million by 2030, according to a new report by Grand View Research, Inc., growing at a CAGR of 8.52% from 2024 to 2030. Factors, such as increasing adoption of cell reprogramming in cancer research and growing focus on cell reprogramming, are expected to drive market growth. In addition, emphasis on collaborations and partnerships among key players is anticipated to boost market growth. Advancements in the mRNA reprogramming technique allow rapid, safe, and efficient generation of clinical-grade human iPS cells using somatic tissue. In addition, as mRNA is lower in size, the transfection process is simpler than other reprogramming vectors. When utilizing difficult-to-reprogram samples, mRNA reprogramming improves reprogramming efficiency by 1%.

Furthermore, this method can generate high-quality human iPS cells from somatic tissue more rapidly and safely, which increases the demand for mRNA reprogramming technology. Furthermore, there is the capability to reprogram human stem cells back to a naive state, allowing replication of the earliest developmental stages. For instance, in March 2022, researchers at the Babraham Institute identified key factors facilitating this reprogramming process. This new knowledge streamlines and expedites the generation of naive pluripotent stem cells for researchers. Moreover, cell reprogramming is experiencing growth due to significant government and public funding. This backing is a response to various benefits it offers to the healthcare sector, particularly in terms of its potential applications in medicine.

Furthermore, cell reprogramming has recently been repositioned from the lab to clinic by researchers. This shift is prominent in various clinical & academic research initiatives, encompassing regenerative medicine, disease modeling, and studies related to medication toxicity & drug discovery. The clinical utility of cell reprogramming, especially in regenerative medicine, has been significant. Increased strategic initiatives aimed at innovative product development through cell reprogramming is due to a growth in the research and academic institute segment. For instance, the California Institute for Regenerative Medicine funded research groups to advance cellular reprogramming into therapeutic applications with a clinical focus.

Cell Reprogramming Market Report Highlights:

  • The mRNA reprogramming technology segment held the largest revenue share of 32.67% in 2023 due to the ease of use, speed, safety, and efficiency while generating high-quality human iPS cells from somatic tissue
  • The research application segment led the market with a share of 67.41% in 2023. One of the main factors driving its growth include ongoing research in the field of cell reprogramming using stem cells
  • The research & academic institute end-use segment held a revenue share of 67.41% in 2023. The growth is due to usage of cell reprogramming in a various clinical & academic research initiatives, including those involving regenerative therapies, disease modeling, and drug toxicity/drug discovery studies
  • North America dominated the global industry in 2023 with a revenue share of 38.65% owing to the presence of key players in this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Information Analysis
    • 1.2.2. Market Platform & Data Visualization
    • 1.2.3. Data Validation & Publishing
  • 1.3. Research Assumptions
  • 1.4. Information Procurement
    • 1.4.1. Primary Research
  • 1.5. Information or Data Analysis
  • 1.6. Market Platform & Validation
  • 1.7. Market Model
  • 1.8. Global Market: CAGR Calculation
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing focus on cell reprogramming
      • 3.2.1.2. Increasing adoption of cell reprogramming in cancer research
      • 3.2.1.3. Emphasis on collaborations and partnerships among key players
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Challenges associated with iPSCs
      • 3.2.2.2. Limited awareness regarding treatment option
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Technology Business Analysis

  • 4.1. Cell Reprogramming Market: Technology Movement Analysis
  • 4.2. Sendai Virus-based Reprogramming
    • 4.2.1. Sendai Virus-based Reprogramming Market, 2018 - 2030 (USD Million)
  • 4.3. mRNA Reprogramming
    • 4.3.1. mRNA Reprogramming Market, 2018 - 2030 (USD Million)
  • 4.4. Episomal Reprogramming
    • 4.4.1. Episomal Reprogramming Market, 2018 - 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Others Reprogramming Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Cell Reprogramming Market: Application Movement Analysis
  • 5.2. Research
    • 5.2.1. Research Market, 2018 - 2030 (USD Million)
  • 5.3. Therapeutics
    • 5.3.1. Therapeutics Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. Cell Reprogramming Market: End-use Movement Analysis
  • 6.2. Research & Academic Institutes
    • 6.2.1. Research & Academic Institutes Market, 2018 - 2030 (USD Million)
  • 6.3. Biotechnology & Pharmaceutical Companies
    • 6.3.1. Biotechnology & Pharmaceutical Companies Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Cell Reprogramming Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. North America Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Competitive Scenario
      • 7.2.2.3. U.S. Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Competitive Scenario
      • 7.2.3.3. Canada Cell Reprogramming Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. UK Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Germany Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. France Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Competitive Scenario
      • 7.3.5.3. Italy Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Competitive Scenario
      • 7.3.6.3. Spain Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Competitive Scenario
      • 7.3.7.3. Denmark Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Competitive Scenario
      • 7.3.8.3. Sweden Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Competitive Scenario
      • 7.3.9.3. Norway Cell Reprogramming Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Japan Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. China Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. India Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Australia Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Thailand Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. South Korea Cell Reprogramming Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Brazil Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Mexico Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Argentina Cell Reprogramming Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. South Africa Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Saudi Arabia Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. UAE Cell Reprogramming Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Kuwait Cell Reprogramming Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Allele Biotech
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. ALSTEM
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. STEMCELL Technologies Inc.
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Merck KGaA
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Bio-Techne
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. REPROCELL
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Lonza
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. FUJIFILM Corporation (Fujifilm Cellular Dynamics)
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Mogrify Limited
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 4 Global Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 5 Global Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 6 Global Cell Reprogramming Market, By Region, 2018 - 2030 (USD Million)
  • Table 7 North America Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
  • Table 8 North America Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 9 North America Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 10 North America Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 12 U.S. Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 14 Canada Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 15 Canada Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 16 Canada Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 17 Europe Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
  • Table 18 Europe Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 19 Europe Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 20 Europe Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 21 UK Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 22 UK Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 23 UK Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 24 Germany Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 25 Germany Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 26 Germany Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 27 France Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 28 France Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 29 France Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 30 Spain Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 31 Spain Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 32 Spain Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 33 Italy Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 34 Italy Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 35 Italy Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 36 Denmark Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 37 Denmark Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 38 Denmark Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 39 Norway Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 40 Norway Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 41 Norway Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 42 Sweden Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 43 Sweden Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 44 Sweden Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 49 China Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 50 China Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 51 China Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 52 Japan Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 53 Japan Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 54 Japan Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 55 India Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 56 India Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 57 India Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 58 South Korea Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 59 South Korea Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 60 South Korea Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 61 Australia Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 62 Australia Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 63 Australia Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 64 Thailand Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 65 Thailand Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 66 Thailand Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 67 Latin America Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
  • Table 68 Latin America Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 69 Latin America Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 70 Latin America Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 71 Brazil Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 72 Brazil Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 73 Brazil Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 74 Mexico Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 75 Mexico Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 76 Mexico Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 78 Argentina Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 79 Argentina Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 80 MEA Cell Reprogramming Market, By Country, 2018 - 2030 (USD Million)
  • Table 81 MEA Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 82 MEA Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 83 MEA Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 85 South Africa Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 86 South Africa Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 87 UAE Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 88 UAE Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 89 UAE Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 91 Saudi Arabia Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 92 Saudi Arabia Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Cell Reprogramming Market, By Technology, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Cell Reprogramming Market, By Application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Cell Reprogramming Market, By End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Cell Reprogramming market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global cell reprogramming market: Technology outlook and key takeaways
  • Fig. 15 Global cell reprogramming market: Technology movement analysis
  • Fig. 16 Global cell reprogramming market, for sendai virus-based reprogramming, 2018 - 2030 (USD Million)
  • Fig. 17 Global cell reprogramming market, for mRNA reprogramming, 2018 - 2030 (USD Million)
  • Fig. 18 Global cell reprogramming market, for episomal reprogramming, 2018 - 2030 (USD Million)
  • Fig. 19 Global cell reprogramming market, for others, 2018 - 2030 (USD Million)
  • Fig. 20 Global cell reprogramming market: Application outlook and key takeaways
  • Fig. 21 Global cell reprogramming market: Application movement analysis
  • Fig. 22 Global cell reprogramming market, for research, 2018 - 2030 (USD Million)
  • Fig. 23 Global cell reprogramming market, for therapeutic, 2018 - 2030 (USD Million)
  • Fig. 24. Global cell reprogramming market: End-use outlook and key takeaways
  • Fig. 25 Global cell reprogramming market: End-use movement analysis
  • Fig. 26 Global cell reprogramming market, for research & academic institutes, 2018 - 2030 (USD Million)
  • Fig. 27 Global cell reprogramming market, for biotechnology & pharmaceutical companies, 2018 - 2030 (USD Million)
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 Regional outlook, 2022 & 2030
  • Fig. 30 North America cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Key country dynamics
  • Fig. 32 U.S. cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 33 Canada Key country dynamics
  • Fig. 34 Canada cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 35 Europe cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 36 Germany Key country dynamics
  • Fig. 37 Germany cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 38 UK Key country dynamics
  • Fig. 39 UK cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 40 France Key country dynamics
  • Fig. 41 France cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 42 Italy Key country dynamics
  • Fig. 43 Italy cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain Key country dynamics
  • Fig. 45 Spain cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark Key country dynamics
  • Fig. 47 Denmark cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden Key country dynamics
  • Fig. 49 Sweden cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 50 Norway Key country dynamics
  • Fig. 51 Norway cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan Key country dynamics
  • Fig. 54 Japan cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 55 China Key country dynamics
  • Fig. 56 China cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 57 India Key country dynamics
  • Fig. 58 India cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 59 Australia Key country dynamics
  • Fig. 60 Australia cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 61 South Korea Key country dynamics
  • Fig. 62 South Korea cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand Key country dynamics
  • Fig. 64 Thailand cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil Key country dynamics
  • Fig. 67 Brazil cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 68 Mexico Key country dynamics
  • Fig. 69 Mexico cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 70 Argentina Key country dynamics
  • Fig. 71 Argentina cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 72 Middle East and Africa cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 73 South Africa Key country dynamics
  • Fig. 74 South Africa cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 75 Saudi Arabia Key country dynamics
  • Fig. 76 Saudi Arabia cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 77 UAE Key country dynamics
  • Fig. 78 UAE cell reprogramming market, 2018 - 2030 (USD Million)
  • Fig. 79 Kuwait Key country dynamics
  • Fig. 80 Kuwait cell reprogramming market, 2018 - 2030 (USD Million)